Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126085991 | 12608599 | 1 | I | 20160524 | 20160725 | 20160729 | 20160729 | PER | US-CELGENEUS-USA-2016076638 | CELGENE | 63.00 | YR | F | Y | 67.50000 | KG | 20160729 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126085991 | 12608599 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | U | U | 21880 | 25 | MG | CAPSULES | ||||||
| 126085991 | 12608599 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Subcutaneous | U | U | 0 | 1.3 | MG/M**2 | INJECTION | BIW | |||||
| 126085991 | 12608599 | 3 | SS | DECADRON | DEXAMETHASONE | 1 | Oral | U | U | 0 | 20 | MG | UNKNOWN | ||||||
| 126085991 | 12608599 | 4 | C | MS CONTIN | MORPHINE SULFATE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126085991 | 12608599 | 5 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN | ||||||||||
| 126085991 | 12608599 | 6 | C | Benazepril-hydrochlorothiazide | 2 | Unknown | 0 | UNKNOWN | |||||||||||
| 126085991 | 12608599 | 7 | C | PAMELOR | NORTRIPTYLINE HYDROCHLORIDE | 1 | Unknown | 0 | UNKNOWN |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126085991 | 12608599 | 1 | Plasma cell myeloma |
| 126085991 | 12608599 | 2 | Plasma cell myeloma |
| 126085991 | 12608599 | 3 | Plasma cell myeloma |
| 126085991 | 12608599 | 4 | Product used for unknown indication |
| 126085991 | 12608599 | 5 | Product used for unknown indication |
| 126085991 | 12608599 | 6 | Product used for unknown indication |
| 126085991 | 12608599 | 7 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126085991 | 12608599 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126085991 | 12608599 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126085991 | 12608599 | 1 | 20160328 | 0 | ||
| 126085991 | 12608599 | 2 | 20160328 | 0 | ||
| 126085991 | 12608599 | 3 | 20160328 | 0 |